Bespoke Extracts Inc
Bespoke Extracts, Inc., together with its subsidiary, Bespoke Extracts Colorado, LLC, produces and sells pre-rolled marijuana cigarettes in the United States. The company owns, manufactures, and distributes a diverse portfolio of cannabis consumer packaged goods under the Fresh Joints, Doobskis, DutchBlunts, and Wee Joints brand names. It also operates a facility dedicated to the production of ma… Read more
Bespoke Extracts Inc (BSPK) - Net Assets
Latest net assets as of September 2025: $-2.60 Million USD
Based on the latest financial reports, Bespoke Extracts Inc (BSPK) has net assets worth $-2.60 Million USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($295.57K) and total liabilities ($2.89 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-2.60 Million |
| % of Total Assets | -878.13% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | -932.86% |
| Growth Volatility | 61.92 |
Bespoke Extracts Inc - Net Assets Trend (2010–2024)
This chart illustrates how Bespoke Extracts Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Bespoke Extracts Inc (2010–2024)
The table below shows the annual net assets of Bespoke Extracts Inc from 2010 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $-2.09 Million | -21.30% |
| 2023-12-31 | $-1.72 Million | -156.59% |
| 2022-12-31 | $-672.10K | -60.70% |
| 2021-12-31 | $-418.24K | +18.58% |
| 2020-12-31 | $-513.66K | -1523.88% |
| 2019-12-31 | $-31.63K | +92.60% |
| 2018-12-31 | $-427.54K | -57.12% |
| 2017-12-31 | $-272.10K | -139.13% |
| 2016-12-31 | $-113.79K | -145.30% |
| 2015-12-31 | $251.18K | -67.48% |
| 2014-12-31 | $772.34K | +15.83% |
| 2013-12-31 | $666.79K | -9.70% |
| 2012-12-31 | $738.43K | +1418.32% |
| 2011-12-31 | $-56.01K | -250.63% |
| 2010-12-31 | $-15.97K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Bespoke Extracts Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 2637008600.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | $24.31 Million | % |
| Total Equity | $-2.09 Million | 100.00% |
Bespoke Extracts Inc Competitors by Market Cap
The table below lists competitors of Bespoke Extracts Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
POMM PROV ZUCK SIED
BE:PPZ
|
$498.46K |
|
T2 Biosystms Inc
NASDAQ:TTOO
|
$498.71K |
|
CHEESECAKE FACTORY (CF2.SG)
STU:CF2
|
$498.83K |
|
DOMINION RES
MU:DOD
|
$498.87K |
|
JUGGERNAUT EXPLOR
F:4JE1
|
$497.66K |
|
Tortoise Energy Infrastructure Closed Fund
NYSE:TYG
|
$497.61K |
|
Bourrelier Group SA
PA:ALBOU
|
$497.54K |
|
Smooth Rock Ventures Corp
PINK:SMRVF
|
$497.40K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Bespoke Extracts Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from -1,724,557 to -2,091,938, a change of -367,381.
- Net loss of 1,037,475 reduced equity.
- Other factors increased equity by 670,094.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-1.04 Million | -49.59% |
| Other Changes | $670.09K | +32.03% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Bespoke Extracts Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2005-12-31 | $-3.26 | $0.06 | x |
| 2006-12-31 | $-6.39 | $0.06 | x |
| 2008-12-31 | $-0.60 | $0.06 | x |
| 2010-12-31 | $-0.08 | $0.06 | x |
| 2011-12-31 | $-0.29 | $0.06 | x |
| 2012-12-31 | $0.58 | $0.06 | x |
| 2013-12-31 | $0.58 | $0.06 | x |
| 2014-12-31 | $0.49 | $0.06 | x |
| 2015-12-31 | $0.10 | $0.06 | x |
| 2016-12-31 | $-0.04 | $0.06 | x |
| 2017-12-31 | $-0.02 | $0.06 | x |
| 2018-12-31 | $-0.54 | $0.06 | x |
| 2019-12-31 | $-0.02 | $0.06 | x |
| 2020-12-31 | $-0.19 | $0.06 | x |
| 2021-12-31 | $-0.08 | $0.06 | x |
| 2022-12-31 | $-0.07 | $0.06 | x |
| 2023-12-31 | $-0.17 | $0.06 | x |
| 2024-12-31 | $-0.19 | $0.06 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Bespoke Extracts Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -92.84%
- • Asset Turnover: 3.11x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-24.63%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2005 | 0.00% | 0.00% | 0.00x | 0.00x | $-6.66K |
| 2006 | 0.00% | 0.00% | 0.00x | 0.00x | $-5.64K |
| 2008 | 0.00% | 0.00% | 0.00x | 0.00x | $-20.42K |
| 2010 | 0.00% | 0.00% | 0.00x | 0.00x | $-238.04K |
| 2011 | 0.00% | 0.00% | 0.00x | 0.00x | $-34.75K |
| 2012 | -53.04% | 0.00% | 0.00x | 1.02x | $-465.53K |
| 2013 | -48.24% | 0.00% | 0.00x | 1.03x | $-388.32K |
| 2014 | -51.02% | 0.00% | 0.00x | 1.01x | $-471.28K |
| 2015 | -291.10% | 0.00% | 0.00x | 1.13x | $-756.28K |
| 2016 | 0.00% | 0.00% | 0.00x | 0.00x | $-353.59K |
| 2017 | 0.00% | 0.00% | 0.00x | 0.00x | $-6.65 Million |
| 2018 | 0.00% | -47801.73% | 0.07x | 0.00x | $-7.57 Million |
| 2019 | 0.00% | 4155.61% | 0.78x | 0.00x | $2.58 Million |
| 2020 | 0.00% | -57621.13% | 0.05x | 0.00x | $-4.59 Million |
| 2021 | 0.00% | -2714.89% | 0.29x | 0.00x | $-923.75K |
| 2022 | 0.00% | -120816.76% | 0.01x | 0.00x | $-4.05 Million |
| 2023 | 0.00% | -188.79% | 2.22x | 0.00x | $-1.31 Million |
| 2024 | 0.00% | -92.84% | 3.11x | 0.00x | $-828.28K |
Industry Comparison
This section compares Bespoke Extracts Inc's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $548,450,613
- Average return on equity (ROE) among peers: -450.37%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Bespoke Extracts Inc (BSPK) | $-2.60 Million | 0.00% | N/A | $498.21K |
| Ascend Wellness Holdings Inc (AAWH) | $142.87 Million | -33.75% | 5.44x | $48.90 Million |
| AB Science S.A (ABSCF) | $10.73 Million | -252.65% | 3.71x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $4.85K | -2005.32% | 0.49x | $603.58K |
| Aurora Cannabis Inc (ACB) | $2.04 Billion | -34.08% | 0.34x | $199.15 Million |
| Acreage Holdings Inc (ACRDF) | $204.27 Million | -30.85% | 1.41x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $7.90 Million | -63.15% | 1.15x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.51 Million | -44.22% | 0.06x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $2.07 Million | -2084.75% | 31.32x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $6.67 Million | 24.51% | 2.78x | $1.80 |
| Adcock Ingram Holdings Limited (AIHLF) | $3.07 Billion | 20.55% | 0.55x | $85.61 Million |